tiprankstipranks
bioAffinity Technologies, Inc. (BIAF)
NASDAQ:BIAF
US Market

bioAffinity Technologies, Inc. (BIAF) Income Statement

21 Followers

bioAffinity Technologies, Inc. Income Statement

Last quarter (Q3 2023), bioAffinity Technologies, Inc.'s total revenue was $298.48K, an increase of 25855.13% from the same quarter last year. In Q3, bioAffinity Technologies, Inc.'s net income was $-2.08M. See bioAffinity Technologies, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20
Total Revenue
$ 319.14K$ 4.80K$ 0.00$ 0.00
Cost of Revenue
$ 75.85K$ 467.00$ 0.00-
Gross Profit
$ 243.12K$ 4.34K$ 0.00-
Operating Expense
$ 2.76M$ 4.02M$ 2.21M$ 2.60M
Operating Income
$ -2.48M$ -3.97M$ -2.21M$ -2.60M
Net Non Operating Interest Income Expense
$ 98.17K$ -2.49M$ -1.00M$ -381.10K
Other Income Expense
$ 12.49K$ 1.65M$ -3.12M$ -4.28M
Pretax Income
$ -5.55M$ -8.15M$ -6.32M$ -7.27M
Tax Provision
$ -4.94K$ 2.46K$ 1.95K$ 2.75K
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -2.25M$ -8.11M$ -6.33M$ -7.27M
Basic EPS
$ -0.64$ -1.81$ -2.32$ -2.66
Diluted EPS
$ -0.64$ -1.81$ -2.32$ -2.66
Basic Average Shares
$ 25.65M$ 4.50M$ 2.73M$ 2.73M
Diluted Average Shares
$ 25.65M$ 4.50M$ 2.73M$ 2.73M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
----
Total Expenses
$ 2.83M$ 4.02M$ 2.21M$ 2.60M
Net Income From Continuing And Discontinued Operation
$ -5.56M$ -8.15M$ -6.33M$ -7.27M
Normalized Income
$ -3.18M-$ -3.52M$ -7.27M
Interest Expense
--$ 1.00M$ 382.17K
EBIT
$ -5.54M$ -5.62M$ -5.32M$ -6.88M
EBITDA
$ -5.43M$ -5.61M$ -5.32M$ -6.86M
Currency in USD

bioAffinity Technologies, Inc. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis